1-6 of 6
Caroline Behler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

Clinical Trials & Observations
Ann S. LaCasce, R. Gregory Bociek, Ahmed Sawas, Paolo Caimi, Edward Agura, Jeffrey Matous, Stephen M. Ansell, Howland E. Crosswell, Miguel Islas-Ohlmayer, Caroline Behler, Eric Cheung, Andres Forero-Torres, Julie Vose, Owen A. O’Connor, Neil Josephson, Yinghui Wang, Ranjana Advani
Journal: Blood
Blood (2018) 132 (1): 40–48.
https://doi.org/10.1182/blood-2017-11-815183
Published: 2018
Includes: Supplemental data
Journal Articles

Brentuximab Vedotin Plus Bendamustine: A Highly Active Salvage Treatment Regimen for Patients with Relapsed or Refractory Hodgkin Lymphoma

Ann S. LaCasce, MD, Gregory Bociek, Ahmed Sawas, Paolo F. Caimi, MD, Edward Agura, Jeffrey Matous, Stephen Ansell, MD PhD, Howland Crosswell, MD, Miguel Islas-Ohlmayer, Caroline Behler, Eric Cheung, Andres Forero-Torres, Julie Vose, Owen A. O'Connor, MD, Neil Josephson, Ranjana Advani
Journal: Blood
Blood (2015) 126 (23): 3982.
https://doi.org/10.1182/blood.V126.23.3982.3982
Published: 2015
Journal Articles

Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma who are Relapsed or Refractory after Frontline Therapy

Ann LaCasce, MD, R. Gregory Bociek, MD, Jeffrey Matous, MD, Ahmed Sawas, MD, Paolo Caimi, MD, Stephen M. Ansell, MD PhD, Miguel Islas-Ohlmayer, MD, Eric Cheung, MD, Edward Agura, MD, Caroline Behler, MD, Howland Crosswell, MD, Julie M. Vose, MD MBA, Neil Josephson, MD, Ranjana Advani, MD
Journal: Blood
Blood (2014) 124 (21): 293.
https://doi.org/10.1182/blood.V124.21.293.293
Published: 2014
Journal Articles

Once a Week Bortezomib with Dexamethasone Is Effective with Limited Toxicity in Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities,

Nikhil C. Munshi, MD, Saem Lee, B.A., Suman Kambhampati, M.D., Michal Rose, M.D., Abid Mohiuddin, M.D., Yvonne Efebera, M.D., Andrew Han, B.A., Antoun Houranieh, RPh., M.S., Ph.D., Abraham Zimelman, M.D., Mary T. Brophy, M.D., Rao Prabhala, Ph.D., Terrence Grady, DO, PhD, Paulette Mehta, M.D, MPH, Teresa G Hayes, M.D., Sarvari Venkata Yellapragada, MBBS, MD, Caroline Behler, M.D., Catherine Klein, M.D., David Roodman, MD, PhD, Alan K. Lichtenstein, M.D.
Journal: Blood
Blood (2011) 118 (21): 3964.
https://doi.org/10.1182/blood.V118.21.3964.3964
Published: 2011
Journal Articles

Dynamic Changes in Macrophage Polarization Correlate with Progression and Response in CNS Lymphoma: Insights Into the Transcriptome of Lymphoma-Associated M2 Macrophages,

Cigall Kadoch, BA, Valerie Wong, Lingjing Chen, Ph.D., Anna Bet-Lachin, Ritu Roy, William Hyun, Caroline Behler, M.D., Clifford Lowell, MD, PhD, James L. Rubenstein, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 3219.
https://doi.org/10.1182/blood.V118.21.3219.3219
Published: 2011
Journal Articles

Interim Results of An Ongoing Clinical Study Suggests Efficacy and Improved Toxicity Profile with Once a Week Bortezomib with Dexamethasone In Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities

Nikhil C. Munshi, M.D., Saem Lee, B.A., Suman Kambhampati, M.D., Abid Mohiuddin, M.D., Michal Rose, M.D., Caroline Behler, M.D., Andrew Han, B.A., Yvonne Efebera, M.D., Antoun Houranieh, RPh., M.S., Ph.D., Mary T. Brophy, M.D., Abraham Zimelman, M.D., Rao H Prabhala, Ph.D., Hussain I. Saba, M.D, Ph.D, Catherine Klein, M.D., Paulette Mehta, M.D, MPH, Teresa Hayes, M.D., David Roodman, M.D, Ph.D, Alan K. Lichtenstein, M.D.
Journal: Blood
Blood (2010) 116 (21): 3061.
https://doi.org/10.1182/blood.V116.21.3061.3061
Published: 2010